Treatment for Anemia, Sickle Cell

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
BC Children's Hospital, Vancouver, Canada
Anemia, Sickle Cell
Eligibility
< 65
All Sexes
What conditions do you have?
Select

Study Summary

This study is evaluating whether folic acid supplementation is safe and effective for children with sickle cell disease.

See full description

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Anemia, Sickle Cell

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome and 7 secondary outcomes in patients with Anemia, Sickle Cell. Measurement will happen over the course of 36 weeks.

36 weeks
Acute Pain Crises
Megaloblastic anemia
Plasma Unmetabolized Folic Acid Concentration
Red Blood Cell Folate Concentration
S-adenosyl-homocysteine Concentration
S-adenosyl-methionine Concentration
Serum Folate Concentration
Total homocysteine Concentration

Trial Safety

Safety Progress

1 of 3

Other trials for Anemia, Sickle Cell

Trial Design

0 Treatment Group

This trial requires 36 total participants across 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 36 weeks
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 36 weeks for reporting.

Who is running the study

Principal Investigator
C. K.
Prof. Crystal Karakochuk, Associate Professor
University of British Columbia

Closest Location

BC Children's Hospital - Vancouver, Canada

Eligibility Criteria

This trial is for patients born any sex aged 65 and younger. There are 2 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Individuals with SCD aged 2-19 y attending British Columbia Children's Hospital
Individuals having received routine daily supplementation of folic acid for the prior 12-weeks

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Anemia, Sickle Cell by sharing your contact details with the study coordinator.